Start Date | 18.09.2025 - 09:30 |
Event End | 18.09.2025 - 15:30 |
Location | Messe BaselMesseplatz, 4005 Basel, Schweiz |
Biotechnology is revolutionizing how we produce chemicals and pharmaceuticals. From alternative production methods like biocatalysis, to the production of modalities like biosimilars, antibody-drug conjugates (ADCs), and synthetic mRNA vaccines, biomanufacturing innovations are opening new frontiers for efficiency and sustainability. Meet experts from big pharma, biotechs and academia who will share the latest developments and innovative approaches.
Get your ticket for free with the Prio Code: scs-ilmac25
Program
Morning Session
09:30 Dr. Anne Marie de Jonge–Schuermans, Sandoz, Basel
«Manufacturing Strategies for Biosimilars »
10:00 Prof. Rebecca Buller, University of Bern, CH
«Engineering Protein Catalysts for Synthetic Applications»
10:30 Coffee Break
10:45 Dr. Bernd Schlereth Araris Biotech, Au, CH
«Novel Linker and Bioconjugation Technology for the Production of Next Generation ADC Candidates with Improved Therapeutic Index (TI)»
11:15 Dr. Florian Kleinbeck, Novartis Pharma AG
«Biocatalysis in Chemical R&D at Novartis – Leveraging its Full Potential Throughout All Development Stages»
11:45 Panel Discussion (Morning Speakers).
Moderation: Sonia Thomson, Communications specialist for science, technology and innovation, FHNW Muttenz
12.30 Lunch Break
Afternoon Session
13:30 Prof. Steve Pascolo, University Hospital UZH, CH
«Synthetic mRNA Vaccines: the Past, the Present and the Future »
14:00 Prof. Carmen Jungo Rhême, HEIA Fribourg
«Quality by Design-Driven Process Characterization of Bacteriophage Production to Combat Antimicrobial-Resistant P. aeruginosa»
14:30 Dr. Serena Bisagni, F. Hoffmann-La Roche AG
«Biocatalysis at Roche: Recent Examples»
15:00 Q&A Session/Discussion
15:30 Aperitif
More Information
Ilmac Website: https://www.ilmac.ch
Ilmac Conference Website: https://scg.ch/ilmac